Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 1, 2006, Pages 1-9

  Zhou, Zhe ^a   Wang, Sheng Qi ^a   Liu, Yong ^a   Miao, Ai Dong ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Cryptotanshinone; Endothelin 1; Nitric oxide; Salvia miltiorrhiza; Vascular endothelial cell

Indexed keywords

CRYPTOTANSHINONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SALVIA MILTIORRHIZA; STIMULATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PHENANTHRENES; RNA, MESSENGER; SALVIA MILTIORRHIZA; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

SALVIA MILTIORRHIZA;

EID: 29044440233     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2005.09.009     Document Type: Article

References (37)

1. A. Lerman, B.S. Edwards, J.W. Hallett, D.M. Heublein, S.M. Sandberg, and J.C. Burnett Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N. Engl. J. Med. 325 1991 997 1001
2. R. Ross Atherosclerosis-An inflammatory disease N. Engl. J. Med. 340 1999 115 126
3. M.R. Dashwood, and J.C. Tsui Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade Atherosclerosis 160 2002 297 304
4. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
5. 2- production in human alveolar macrophages Am. J. Physiol. 261 1991 L478 L484
6. X.L. Lei, and G.C.Y. Chiou Studies on cardiovascular actions of Salvia miltiorrhiza Am. J. Chin. Med. 4 1986 26 32
7. X.Y. Ji, B.K.H. Tan, and Y. Zhu Salvia miltiorrhhiza and ischemic diseases Acta Pharmacol. Sin. 21 2000 1089 1094
8. Y.Z. Zhu, Y.C. Zhu, Z.J. Wang, Q. Lu, H.S. Lee, and T. Unger Time-dependent apoptotic development and pro-apoptotic genes expression in rat heart after myocardial infarction Jpn. J. Pharmacol. 86 2001 255 258
9. I.S. Lay, C.C. Hsieh, J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague-Dawley rats J. Surg. Res. 115 2003 279 285
10. M. Xue, Y. Cui, H.Q. Wang, Z.Y. Hu, and B. Zhang Reversed-phase liquid chromatographic determination of cryptotanshinone and its active metabolite in pig plasma and urine J. Pharm. Biomed. 21 1999 207 213
11. N. Hogg, and B. Kalyanaraman Nitric oxide and lipid peroxidation Biochim. Biophys. Acta 1411 1999 378 384
12. H. Li, N. Xia, I. Brausch, Y. Yao, and U. Forstermann Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells J. Pharmacol. Exp. Ther. 310 2004 926 932
13. N. Mitsutomi, C. Akashi, J. Odagiri, and Y. Matsumura Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells Eur. J. Pharmacol. 364 1999 65 73
14. M. Ohkita, M. Takaoka, M. Sugii, Y. Shiota, R. Nojiri, and Y. Matsumura The role of nuclear factor-kappa B in the regulation of endothelin-1 production by nitric oxide Eur. J. Pharmacol. 472 2003 159 164
15. A.P. Smith, E.A. Demoncheaux, and T.W. Higenbottam Nitric oxide gas decreases endothelin-1 mRNA in cultured pulmonary artery endothelial cells Nitric Oxide 6 2002 153 159
16. J.Y. Chang, C.Y. Chang, C.C. Kuo, L.T. Chen, Y.S. Wein, and Y.H. Kuo Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells Mol. Pharmacol. 65 2004 77 84
17. J.L. Wallace, G. Rizzo, G. Cirino, P.D. Soldato, and S. Fiorucci Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappa B J. Pharmacol. Exp. Ther. 310 2004 1096 1102
18. K. Ruscher, M. Reuter, D. Kupper, G. Trendelenburg, U. Dirnagl, and A. Meisel A fluorescence based non-radioactive electrophoretic mobility shift assay J. Biotechnol. 78 2000 163 170
19. J.Y. Park, Y.M. Kim, H.S. Song, K.Y. Park, Y.M. Kim, M.S. Kim, Y.K. Pak, I.K. Lee, J.D. Lee, S.J. Park, and K.U. Lee Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-kappa B Biochem. Biophys. Res. Commun. 303 2003 891 895
20. B. Tiziana, C. Laura, C. Salvatore, B. Daniela, P. Michela, B. Giuliana, C. Francesco, and F. Roberto Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells J. Mol. Cell. Cardiol. 37 2004 939 945
21. M. Yoshizumi, Y. Fujita, Y. Izawa, Y. Suzaki, M. Kyaw, N. Ali, K. Tsuchiya, S. Kagami, S. Yano, S. Sone, and T. Tamaki Ebselen inhibits tumor necrosis factor-a-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells Exp. Cell Res. 292 2004 1 10
22. J.M. Cacicedo, N. Yagihashi, J.F. Keaney Jr., N.B. Ruderman, and Y. Ido AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells Biochem. Biophys. Res. Commun. 324 2004 1204 1209
23. Z.Y. Xia, J.Z. Gu, D.M. Ansley, F. Xia, and J.F. Yu Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease J. Thorac. Cardiovasc. Surg. 126 2003 1404 1410
24. Y.J. Wu, C.Y. Hong, S.J. Lin, P. Wu, and M.S. Shiao Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza Arterioscler., Thromb., Vasc. Biol. 18 1998 481 486
25. Y.H. Chen, S.J. Lin, H.H. Ku, M.S. Shiao, F.Y. Lin, J.W. Chen, and Y.L. Chen Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells J. Cell. Biochem. 82 2001 512 521
26. Y.L. Chen, S.P. Yang, M.S. Shiao, J.W. Chen, and S.J. Lin Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits J. Cell. Biochem. 83 2001 484 493
27. A. Yagi, K. Fujimoto, K. Tanonaka, K. Hirai, and S. Takeo Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements Planta Med. 55 1989 51 54
28. H.C. Lin, H.Y. Ding, and W.L. Chang Two new fatty diterpenoids from Salvia miltiorrhizae J. Nat. Prod. (Lloydia) 64 2001 648 650
29. H.S. Xu, J. Duan, S. Dai, Y. Wu, R. Sun, and J. Ren Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells Endocrine 25 2004 235 245
30. B. Shrestha, C. Hidai, H. Ikeda, M. Okada-Ohno, H. Kasanuki, and M. Kawana Endothelin-1 gene expression in endothelial cells is potently inhibited by a vasodilator, dilazep Hypertens. Res. 27 2004 409 415
31. G.M. Rubanyi, and M.A. Polokoff Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol. Rev. 46 1994 325 415
32. T. Collins Biology of disease: endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion Lab. Invest. 68 1993 499 508
33. E. Hamaguchi, T. Takamura, A. Shimizu, and Y. Nagai Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappa B- dependent pathways in cultured human umbilical vein endothelial cells J. Pharmacol. Exp. Ther. 307 2003 987 994
34. S. Demczuk, M. Harbers, and B. Vennstrom Identification and analysis of all components of a gel retardation assay by combination with immunoblotting Proc. Natl. Acad. Sci. U. S. A. 90 1993 2574 2578
35. T. Michel, T., and O. Feron Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100 1997 2146 2152
36. D. Annane, S. Sanquer, V. Sebille, A. Faye, D. Djuranovic, J.C. Raphael, P. Gajdos, and E. Bellissant Compartmentalised inducible nitric-oxide synthase activity in septic shock Lancet 355 2000 1143 1148
37. M.Z. Xie, and Z.F. Shen Absorption, distribution, excretion and metabolism of cryptotanshinone Yao Xue Xue Bao 18 1983 90 96